The Pennine Acute Hospitals
NHS Trust Formulary
 
back
2 Cardiovascular system
02-03-02 Supraventricular arrhythmias

Adenosine Adenocor®
Formulary
Injection
Infusion

View adult BNF  View SPC online  View childrens BNF
Dronedarone Multaq®
Restricted
Tablets

Restricted Item Cardiologist/stroke physician initiation only

Dronedarone should only be initiated as a second line treatment option for non-permanent atrial fibrillation after:
  • standard NICE first line options are either cautioned/contraindicated or have failed
  • and if
  • amiodarone use is cautioned/intolerated
  • It should only be used in clinically stable patients, and is not recommended for those with NYHA Class III/IV heart failure.

    Dronedarone is not recommended for patients with permanent AF.

    See attached guidance for more information.
    Link  MHRA Safety Alert: Dronedarone cardiovascular, hepatic and pulmonary adverse events new restrictions and monitoring requirements
    Link  NICE TA197: Atrial fibrillation - dronedarone
     

    Restricted Drug Green 3 View adult BNF  View SPC online  View childrens BNF
    Mexiletine
    Formulary

    unlicensed unlicensed


    Restricted Item Cardiology consultant only


    Unlicensed import


    View adult BNF  View SPC online  View childrens BNF